We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Information about how the Competition and Markets Authority responded to the coronavirus (COVID-19) outbreak.
This collection brings together all the Competition and Markets Authority's (CMA) board meeting minutes.
Letters sent by the Competition and Markets Authority (CMA) to companies about their non-compliance with market investigation orders and undertakings.
Information about what to do if you receive a warning or advisory letter from the CMA.
All data on external disclosures made to the CMA
Tell the CMA about issues with a business, a market, or to provide information about a new or existing case.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Documents relating to workforce management information summary data for the Competition and Markets Authority.
Tell the CMA about competition and consumer issues.
Karen Croxson joined the CMA in September 2023 and was appointed as its first Chief Data, Technology and Insight Officer on 2 April 2024. Karen is a member of the Senior Executive Team and oversees all the CMA’s work related...
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
The Competition and Markets Authority (CMA) has a statutory duty to comply with the Public Records Act 1958 (PRA).
The CMA has published its response to DESNZ’s consultation on an open data scheme and ongoing monitoring function for road fuel prices.
The CMA is investigating suspected anti-competitive conduct in relation to the recycling of old or written-off vehicles, specifically cars and vans, also known as ‘end-of-life vehicles’ or ELVs.
The investigation will consider whether Vifor Pharma has been engaging in anti-competitive conduct.
The CMA will not recommend renewing a ‘block exemption’, which provides an exemption from competition law for certain forms of cooperation between liner shipping companies.
The CMA has today published its main concerns following an initial review into the veterinary sector.
Letter to Calor Gas Limited about a breach of the Domestic Bulk Order and a breach of the Metered Estates Order.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.